Home
Mybacs AG

Mybacs AG Market Share Analysis for August 2026

Innovative und hochdosierte synbiotische Nahrungsergänzungsmittel von mybacs. Darmgesundheit neu gedacht.

Lifestyle > Beauty and Cosmetics

Domainmybacs.com

Year Founded2018

Employees51 - 200

Annual Revenue$2M - $5M

Mybacs AG

Mybacs AG (including company regionals)

mybacs.com

See more website traffic and engagement information

Mybacs AG Revenue up to August 2026 is 2M - 5M

revenue generated by Mybacs AG top domains

Mybacs AG top domains revenue over 3 years

Revenue for Mybacs AG top domains

mybacs.com2M - 5M

See more with Sales Intelligence

Total visits to Mybacs AG's top domains

Understand Mybacs AG market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

mybacs.com78.3K

See more with Sales Intelligence

Avg. visit duration in Mybacs AG's top domains

Analyze Mybacs AG engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

mybacs.com00:01:30

See more with Sales Intelligence

Avg. pageviews on Mybacs AG's top domains

See how Mybacs AG keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

mybacs.com3.39

See more with Sales Intelligence

Mybacs AG top competitors by domain

Top similar sites in August 2026, ranked by their affinity

biogena-one.comCompany NameBIOGENA ONEEmployees201 - 500HQAustria, SalzburgAnnual revenue--Total visits94.4KHealth > Nutrition Diets and Fitness

Top technologies used by Mybacs AG

These are the website technologies, by industry, used by Mybacs AG top domains

Payment & Currencies (27)

Cart Functionality

Advertising (19)

DoubleClick

Conversion & Analytics (19)

Google Analytics

Social (7)

Google+ Platform

More Technologies

15

See all

News & Signals from Mybacs AG

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsNaturalX invests into Mybacs in Series A."naturalX led our Series-A round and has been an exceptional partner, bringing not only capital but also invaluable knowledge of the nutritional supplement and broader consumer health market," said Carl-Philipp von Polheim, Founder of mybacs, a leading DTC probiotic subscription startup.